Viewing Study NCT07479732


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-29 @ 11:40 PM
Study NCT ID: NCT07479732
Status: RECRUITING
Last Update Posted: 2026-03-18
First Post: 2026-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module